Bayer’s Asundexian Cuts Recurrent Stroke Risk by 26% in Phase 3 Trial 7 February 2026·534 words·3 mins Stroke Prevention Cardiovascular Drugs Clinical Trials Pharmaceuticals Neurology
Why Alzheimer’s Trials Must Address Sex Differences 30 December 2025·463 words·3 mins Medical Research Alzheimer’s Clinical Trials Precision Medicine
Sanofi’s AlphaMedix Hits Key Efficacy Goals in Phase 2 Neuroendocrine Tumor Trial 9 October 2025·625 words·3 mins Sanofi AlphaMedix Radioligand Therapy Neuroendocrine Tumors Oncology Biotech Clinical Trials
How AI and Data are Shaping the Future of Inclusive Clinical Trials 22 September 2025·1108 words·6 mins AI in Healthcare Clinical Trials Diversity in Clinical Trials Patient Recruitment
